Study Purpose: The purpose of this study is to learn more about the use of the RevitaTM System for the treatment of Type 2 diabetes.
To be enrolled in this study, you must meet certain requirements. You may be eligible to participate if you meet the following criteria:
Study Duration: up to 60 weeks
• 3 Screening visits
• Up to 11 Outpatient visits (including procedure visit)
• Up to 10 Phone calls
Age: 28-65 years old
Sex: Male & Female
• BMI 28-40 kg/m2
• Type II Diabetes (at least three years)
• Prescribed with 2 OADs, one of them metformin
• Physical exam, vital signs, height, and weight, EKG, fasting labs
• IV insertion
• Multiple blood draws
• Phone calls
• Urine Screen
• Pregnancy Test
Compensation: offered up to $2,325
Please call (407) 303-7193 or fill out the Contact Form below for more information.
This study is currently enrolling.